The use of selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants among women in midlife didn’t lead to a greater rate of bone loss, a prospective cohort study found. via MedPage Today
-MedShadow Staff
The use of selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants among women in midlife didn’t lead to a greater rate of bone loss, a prospective cohort study found. via MedPage Today
-MedShadow Staff
FIND ARTICLES
Conditions
Symptoms & Concerns
Medications
SUPPORT
Contribute
Donate
Contact
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward
Login below or Register Now.
Already registered? Login.